<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37495641</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Prospective study to evaluate quality of life in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>12074</StartPage><MedlinePgn>12074</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12074</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-39147-w</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative rare disease characterized by symptoms and signs in the upper and lower motor neurons, leading to progressive neuro-degeneration and muscle atrophy. Our objective was to analyse the quality of life (QoL) in patients with ALS and compare with general population and with patients with cancer. Prospective study from consecutive ALS patients in one center. In order to assess quality of life, during the first visit three questionnaires were administered: Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), Short Form-36 (SF-36) and EuroQoL 5D (EQ-5D). We compared SF-36 of ALS patients with a reference population (n&#x2009;=&#x2009;9151), and we compared the EQ-5D index score of ALS patients versus patients with cancer in the same area and in the same period (2015-2018). Between June 2015 and September 2017, 23 were included. The mean age was 65.1&#x2009;&#xb1;&#x2009;12.6&#xa0;years and 56.5% were women. Compared with the general population, patients with ALS showed lowest QoL (p&#x2009;&lt;&#x2009;0.05) in all the dimensions, with a very important impairment in physical function (median: 0; p25-75: 0-10) and physical role (median: 0; p25-75: 0-6.25). In EQ-5D questionnaire, patients with ALS presented an EQ-5D index score of 0.21&#x2009;&#xb1;&#x2009;0.39 (mean&#x2009;&#xb1;&#x2009;standard deviation) with a visual analog scale (VAS) score of 0.32&#x2009;&#xb1;&#x2009;0.24. Compared with an oncological population, patients with ALS had a worse EQ-5D index score both clinically and statistically (0.21&#x2009;&#xb1;&#x2009;0.39 vs. 0.77&#x2009;&#xb1;&#x2009;0.27; p&#x2009;&lt;&#x2009;0.05). We demonstrate a poorer quality of life in patients with ALS is poor, and clinically and statistically worse than in patients with cancer or general population. New studies need to evaluate the impact of strategies in this population to improve the quality of life.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caballero-Eraso</LastName><ForeName>Candela</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Carlos III Health Institute, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrera-Cueva</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Benito Zorrero</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Ramirez</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Carlos III Health Institute, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marin-Romero</LastName><ForeName>Samira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asensio-Cruz</LastName><ForeName>Maria Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Carlos III Health Institute, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrot-Cortes</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Carlos III Health Institute, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jara-Palomares</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Surgical Unit of Respiratory Diseases, Hospital Virgen del Roc&#xed;o, Av. Manuel Siurot S/N, 41013, Seville, Spain. luisoneumo@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Carlos III Health Institute, Madrid, Spain. luisoneumo@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010361" MajorTopicYN="N">Patients</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>LJP has received honoraria for presentations from Bayer Hispania, Actelion, Pfizer, Rovi, LEO Pharma, Daiichi Sankyo grants, personal fees and non-financial support from LEO Pharma, Menarini, MSD, and Roche. The rest of authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37495641</ArticleId><ArticleId IdType="pmc">PMC10372064</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-39147-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-39147-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019;32(5):771. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Groft SC, Posada M, Taruscio D. Progress, challenges, and global approaches to rare diseases. Acta Paediatr. 2021 doi: 10.1111/apa.15974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15974</ArticleId><ArticleId IdType="pubmed">34105798</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)&#x2014;revised report of an EFNS task force. Eur. J. Neurol. 2012;19(3):360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert C, Wasner M, Borasio GD. Patients&#x2019; assessment of quality of life instruments: A randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2001;191(1&#x2013;2):103&#x2013;109. doi: 10.1016/S0022-510X(01)00612-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00612-8</ArticleId><ArticleId IdType="pubmed">11676999</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier A, Vignola A, Calvo A, et al. A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology. 2007;68(12):923&#x2013;926. doi: 10.1212/01.wnl.0000257093.53430.a8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000257093.53430.a8</ArticleId><ArticleId IdType="pubmed">17372127</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin M, Gavin T, Mays I, Heverin M, Hardiman O. Individual quality of life in spousal ALS patient-caregiver dyads. Health Qual. Life Outcomes. 2020 doi: 10.1186/s12955-020-01551-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01551-5</ArticleId><ArticleId IdType="pmc">PMC7682006</ArticleId><ArticleId IdType="pubmed">33225955</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero-Eraso C, Lopez-Ramirez C, Marin-Romero S, et al. Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study. Thromb. Res. 2022;211:81&#x2013;84. doi: 10.1016/J.THROMRES.2022.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.THROMRES.2022.01.002</ArticleId><ArticleId IdType="pubmed">35123304</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos TS, Rodr&#xed;guez-Santos F, Esteban J, V&#xe1;zquez PC, Mora Pardina JS, Carmona AC. Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) Amyotroph. Lateral Scler. 2010;11(5):475&#x2013;477. doi: 10.3109/17482968.2010.489115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.489115</ArticleId><ArticleId IdType="pubmed">20509746</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso J, Prieto L, Ant&#xf3; JM. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results. Med. Clin. 1995;104(20):771&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">7783470</ArticleId></ArticleIdList></Reference><Reference><Citation>Group TE EuroQol&#x2014;A new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199&#x2013;208. doi: 10.1016/0168-8510(90)90421-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8510(90)90421-9</ArticleId><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr-Hill RA. Health related quality of life measurement&#x2014;Euro style. Health Policy. 1992;20(3):321&#x2013;328. doi: 10.1016/0168-8510(92)90164-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8510(92)90164-7</ArticleId><ArticleId IdType="pubmed">10118016</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual. Life Outcomes. 2007 doi: 10.1186/1477-7525-5-70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-5-70</ArticleId><ArticleId IdType="pmc">PMC2248572</ArticleId><ArticleId IdType="pubmed">18154669</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin-Barrera L, Mu&#xf1;oz-Martin AJ, Rios-Herranz E, et al. A case-control analysis of the impact of venous thromboembolic disease on quality of life of patients with cancer: Quality of life in cancer (QCA) study. Cancers. 2020 doi: 10.3390/cancers12010075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12010075</ArticleId><ArticleId IdType="pmc">PMC7017186</ArticleId><ArticleId IdType="pubmed">31888065</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Campo Y, Homedes C, Lazaro A, et al. Observational study of patients in Spain with amyotrophic lateral sclerosis: Correlations between clinical status, quality of life, and dignity. BMC Palliat Care. 2017 doi: 10.1186/s12904-017-0260-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12904-017-0260-6</ArticleId><ArticleId IdType="pmc">PMC5735656</ArticleId><ArticleId IdType="pubmed">29258495</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler. 2014;15:9&#x2013;14. doi: 10.3109/21678421.2013.805784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.805784</ArticleId><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2015;86(1):38&#x2013;44. doi: 10.1136/jnnp-2013-306589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306589</ArticleId><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>